Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

Segmented by Drugs;

Approved Drugs - Eculizumab (Soliris) and Ravulizumab (Ultomiris), Pipeline Drugs - APL-2, Nomacopan (Coversin), ACH-4471 and Other Pipeline Drugs.

Segmented by Route of Administration;

Injection/Infusion and Oral.

Segmented by Distribution Channel;

Hospital Pharmacies, Retail Pharmacies and Online Pharmacies.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).
Report ID: Rn129389833 Published Date: July, 2022 Updated Date: August, 2022

Introduction

Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market (USD Million), 2018 - 2028

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2018 - 2028
2018 94.3
2019 97.7
2020 108.7
2021 113.2
2022 114.9
2023 125.0
2024 141.1
2025 151.8
2026 159.0
2027 166.1
2028 182.4

In the year 2021, the Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market was valued at USD 3,352.60 million. The size of this market is expected to increase to USD 6,812.66 million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of 10.7%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drugs
    2. Market Snapshot, By Route of Administration
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By Region
    5. Market Opportunity Map
  4. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Scenario
    3. Pipeline Analysis/Technological Advancements
    4. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    5. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market, By Drugs, 2019 - 2029 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Approved Drugs
          1. Introduction
          2. Market Share Analysis, 2022 and 2028 (%)
          3. Y-o-Y Growth Analysis, 2019 - 2028
          4. Segment Trends
            1. Eculizumab (Soliris)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            2. Ravulizumab (Ultomiris)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Pipeline Drugs
          1. Introduction
          2. Market Share Analysis, 2022 and 2028 (%)
          3. Y-o-Y Growth Analysis, 2019 - 2028
          4. Segment Trends
            1. APL-2
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            2. Nomacopan (Coversin)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            3. ACH-4471
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            4. Other Pipeline Drugs
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    2. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market, By Route of Administration, 2019 - 2029 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Injection/Infusion
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Oral
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    3. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market, By Distribution Channel, 2019 - 2029 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Hospital Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Retail Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Online Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    4. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market, By Geography, 2019 - 2029 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
        4. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
        5. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Alexion Pharmaceuticals, Inc
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Apellis Pharmaceuticals
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Amgen, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Akari Therapeutics
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Achillion Pharmaceuticals, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Ra Pharmaceuticals, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Novartis AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Regeneron Pharmaceuticals, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      9. Chugai Pharmaceutical Co., Ltd. (Roche AG)
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      10. NovelMed Therapeutics
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      11. Alnylam Pharmaceuticals, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Radiology
Global Radiotherapy Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Radiotherapy Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Short Bowel Syndrome
Global Short Bowel Syndrome Therapeutics Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Short Bowel Syndrome Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Hematology
Global Thrombocytopenia Therapeutics Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Thrombocytopenia Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Neurology
Global Vagus Nerve Stimulation (VNS) Devices Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Vagus Nerve Stimulation (VNS) Devices Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...